Immunomedics (IMMU) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Christopher Moylen who wrote (73)	12/16/1996 4:59:00 PM
From: M. LaMancha	of 371

Optimism grounded in fact is good to hear. I appreciate your analysis. I've spoken in the past with Paul Herron, the IR guy. He's always careful to not overstate. This seems like a well managed company, particularly in light of alliances on CEA-Scan struck with Mallinckrodt. I would not be surprised if the pending Leukoscan approval in Europe and FDA submission were milestones in their relationship with Mallinckrodt. In speaking with Mallinckrodt, I found that company is focusing on core markets, namely imaging and they are looking for getting deeper into nuclear medicine. Several other companies on the leading edge of development are already taken and IMHO Mallinckrodt will probably look to expand its relationship with Immunomedics. The involvement of Lehman brothers is a reasonable step in that direction, looking for outside advice on how to structure such agreements. Ultimately, of course, the Immunomedics is hoping Lehman Brothers will rate the company's efforts favorably and cover the stock. All in all, I agree that IMMU is a good stock at this price. We'll see what happens.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next